Results of a survey on applied quality standards in non-interventional studies among the members of the German Association of Research-based Pharmaceutical Companies.
After the regulatory approval has been obtained, epidemiological studies are acknowledged scientific medical research methods for a new drug which provide additional knowledge about routine application of the drug in clinical daily routine. These studies are performed according to the recommendations of both international and national expert associations, the recommendations of the higher federal authorities in Germany and according to the recommendations of the associations of the pharmaceutical industry. Two surveys among the member companies of the Association of Research-based Pharmaceutical Companies investigated the status of the implementation of the recommendations in the years 2008 and 2010 and compared the results with each other. It could be shown that these recommendations were implemented successfully and were fully adhered to during the conduct of non-interventional studies in Germany. The recommendations define a quality standard which justifies a high level of confidence in the validity of the data collected and the results from these investigations.
Pfizer Pharma GmbH, Berlin, Germany. michael.hahn@pfizer.com
Michael
M
Hahn
Thorsten
T
Ruppert
Thomas D
TD
Bethke
Ferdinand
F
Hundt
D003625:Data Collection; D004345:Drug Industry / Q000592:standards* / Q000706:statistics & numerical data*; D016021:Epidemiologic Studies; D004813:Epidemiology / Q000592:standards*; D005858:Germany; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care / Q000706:statistics & numerical data*